Oxygen therapy for newborn, child, and maternal health

Increasing access to oxygen through normative policy change

PATH is working to increase access to oxygen therapy for newborns, children, and pregnant women through normative policy change. In collaboration with partners and expert advisers, PATH is facilitating the inclusion of expanded uses of oxygen on the WHO EML. Ensuring such global endorsement and normative guidance for the broader applications of oxygen may foster a more enabling environment for oxygen delivery at the national level.

PATH is also packaging and disseminating a series of evidence-based advocacy resources (policy primer) to enable country-based advocates to engage national decision-makers and stimulate their support for increased access to oxygen. Resources will include content on global evidence, normative policies and guidance, and communications assets, and will be designed to be adaptable at the national level.

Reliable provision of oxygen therapy and accurate identification of hypoxemia is essential in reducing mortality. Identifying barriers to access and ensuring inclusion of oxygen and pulse oximetry in current normative policies, treatment guidelines, health budgeting, and system infrastructure (e.g. maintenance and supply chain management) are key to improving oxygen availability.

Photo: PATH/Mike Wang